Managing Influenza in the High-Risk Patient

Managing Influenza and the High-Risk Patient is a live complimentary 1-hour CME webinar with a nationally recognized infectious disease specialist who will provide expert guidance on managing influenza in children, older adults, those with rheumatologic diseases, cancer, or other patients with immunocompromising conditions.

This event is hosted by CCO’s sister company, Practicing Clinicians Exchange (PCE).

Registration information can be found here:

June 5, 2021:
June 13, 2021:
June 26, 2021:


  • Introduction
  • Identification and Diagnosis
    • High-risk patient populations
    • Differential diagnosis
    • Diagnostic testing
  • Efficacy, Safety, Resistance Evidence
    • Approved therapies
    • Emerging agents
  • Individualizing Treatment
    • Guideline recommendations:
      • Adults
      • Children
    • Special populations
      • Rheumatology
      • Oncology
      • Elderly
      • Immunocompromised
      • Other considerations
  • Patient/caregiver education
  • Q & A session


Date / Time
Event Details


Paul G. Auwaerter, MD, MBA

Sherrilyn and Ken Fisher Professor of Medicine
Divisions of Infectious Diseases and General Internal Medicine
Clinical Director
Division of Infectious Diseases
Johns Hopkins School of Medicine
Baltimore, Maryland

Michael G. Ison, MD, MS

Divisions of Infectious Diseases and Organ Transplantation
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Tracy Zivin-Tutela, MD

Infectious Diseases Specialist of New Jersey
RWJ Barnabas Health and Saint Peter's University Hospital
New Brunswick, New Jersey

Goal Statement
This goal of this webinar is to provide expert guidance and strategies for treating and managing influenza in high-risk populations.

Target Audience
Physicians, NPs, and PAs that specialize in caring for high-risk populations.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Plan treatment strategies for flu treatment for adult patients at high risk for complications
  • Summarize the available and emerging options for management of influenza in high-risk patients
  • Individualize flu treatment for pediatric patients based on recent trial data and current recommendations


Joint Accreditation Statement

In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

Practicing Clinicians Exchange designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit

Physician Assistant Continuing Medical Education

Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclosure of Conflicts of Interest 
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.